Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy-Reference-Cited by-同舟云学术

Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy

Published:2020-10-02 Issue:40 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Nguyen Anh¹^ORCID,Ramesh Anujan²,Kumar Sahana¹^ORCID,Nandi Dipika³,Brouillard Anthony¹^ORCID,Wells Alexandria³^ORCID,Pobezinsky Leonid³⁴^ORCID,Osborne Barbara³⁴^ORCID,Kulkarni Ashish A.¹²³⁴^ORCID

Affiliation:

1. Department of Chemical Engineering, University of Massachusetts, Amherst, MA, USA.

2. Department of Biomedical Engineering, University of Massachusetts, Amherst, MA, USA.

3. Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA, USA.

4. Center for Bioactive Delivery, Institute for Applied Life Sciences, University of Massachusetts, Amherst, MA, USA.

Abstract

Granzyme B nanoreporter can distinguish between highly responsive and poorly responsive tumors.

Funder

National Institutes of Health

American Cancer Society

Cancer Research Institute

Melanoma Research Alliance

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference45 articles.

1. Cancer immunotherapy comes of age

2. The blockade of immune checkpoints in cancer immunotherapy

3. Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future

4. Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

5. Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Granzyme B-targeted Smart Positron Emission Tomography Probes for Monitoring Tumor Early Response to Immunotherapy;ACS Nano;2024-07-13

2. Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells;Journal of Controlled Release;2024-05

3. EGCG suppresses PD-1 expression of T cells via inhibiting NF-κB phosphorylation and nuclear translocation;International Immunopharmacology;2024-05

4. Dual‐Sensing Nanoreporter for Dynamic and High‐Throughput Monitoring of Immune Checkpoint Inhibitor Responses in Tumor‐Derived Organoids;Advanced Functional Materials;2024-03-30

5. A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors;Journal of the American Chemical Society;2024-03-13